Table 3.
Comorbidities at diagnosis and at most recent follow-up among SV patients who never developed metastases (n = 76*)
| At diagnosis, N (%) | At most recent follow-up, N (%) | p-value | |
|---|---|---|---|
| Peripheral neuropathy | 6 (8) | 54 (71) | < 0.001 |
| Anemia | 12 (16) | 37 (48) | < 0.001 |
| Hypertension | 29 (38) | 32 (42) | 0.250 |
| Gastrointestinal disorders | 22 (29) | 27 (36) | 0.063 |
| Anxiety | 11 (14) | 25 (33) | < 0.001 |
| Elevated cholesterol | 18 (24) | 22 (29) | 0.125 |
| Lymphedema | 0 (0) | 20 (26) | < 0.001 |
| Thyroid problems | 14 (18) | 19 (25) | 0.063 |
| Arthritis | 14 (18) | 18 (24) | 0.125 |
| Depression | 9 (12) | 18 (24) | 0.004 |
| Deep venous thrombosis | 6 (8) | 12 (16) | 0.031 |
| Asthma | 7 (9) | 7 (9) | 1.000 |
| Diabetes without complications | 6 (8) | 8 (10) | 0.500 |
| Chronic pulmonary disease | 5 (7) | 7 (9) | 0.500 |
| Gastrointestinal bleed | 2 (3) | 7 (9) | 0.063 |
| Congestive heart failure | 0 (0) | 5 (7) | 0.063 |
| Secondary cancers | 1 (1) | 1 (1) | 1.000 |
Statistics for percentage with a particular comorbidity at diagnosis and at most recent follow-up compared using the sign binomial test
*
For 1 patient no comorbidity data were available